Patents by Inventor Henrik Dalbøge

Henrik Dalbøge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230279233
    Abstract: The present invention provide scalable methods of producing newly identified atrorosin pigments, compositions comprising the pigments, lakes and dyes and uses thereof for colorings foods, such as dairy, meat substitutes or candy.
    Type: Application
    Filed: July 6, 2021
    Publication date: September 7, 2023
    Inventors: Henrik Dalbøge, Anders Sebastian Rosenkrans Ødum
  • Patent number: 6270968
    Abstract: A method for providing a hybrid polypeptide having an activity of interest, by i) performing PCR amplification using an uncharacterized DNA sample and oligonucleotide primers with homology to one or more known genes encoding a polypeptide exhibiting said activity of interest, to obtain one or more PCR products, ii) linking the obtained PCR products to a 5′ structural gene sequence and a 3′ structural gene sequence, wherein the 5′ and 3′ structural gene sequences are derived from one or more genes encoding a polypeptide exhibiting said activity of interest, to form hybrid DNA sequences, iii) expressing the resulting hybrid DNA sequences, and iv) screening the hybrid polypeptides to identify a sequence encoding a polypeptide exhibiting said activity of interest or a related activity.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: August 7, 2001
    Assignee: Novozymes A/S
    Inventors: Henrik Dalbøge, Thomas Sandal, Markus Sakari Kauppinen, Børge Diderichsen
  • Patent number: 6265185
    Abstract: Novel yeast promoters for either EF1-alpha protein or ribosomal protein S7 gene suitable for expression cloning in yeast and heterologous expression of proteins in yeast. The yeast promoters are preferably active in the pH range 4-11 without peptone and obtained from the yeast strain Yarrowia lipolytica.
    Type: Grant
    Filed: October 19, 1998
    Date of Patent: July 24, 2001
    Assignee: Novozymes A/S Patents
    Inventors: Sven Muller, Henrik Dalbøge
  • Patent number: 6228630
    Abstract: An enzyme preparation comprising (a) first enzyme with xylanase activity and (b) a second enzyme having cellulotytic, xylanolytic or pectinolytic activity and are supported by the specification.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: May 8, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Lene Venke Kofod, MArkus Sakari Kauppinen, Stephan Christgau, Hans Peter Heldt-Hansen, Henrik Dalbøge, Lene Nonboe Andersen, Joan Qi Si, Tina Sejersgåard Jacobsen, Niels Munk, Anette Müllertz
  • Patent number: 6214598
    Abstract: An enzyme from Aspergillus aculeatus exhibiting endoglucanase activity encoded by the DNA sequence of SEQ ID NO:17 or 18, and useful for degrading plant cell walls.
    Type: Grant
    Filed: November 19, 1997
    Date of Patent: April 10, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Dalboege, Lene Nonboe Andersen, Lene Venke Kofod, Markus Sakari Kauppinen, Stephan Christgau
  • Patent number: 6197564
    Abstract: A DNA construct encoding an enzyme(s) exhibiting xylanase activity, which enzyme is immunologically reactive with antibody raised against a purified xylanase derived from Aspergillus aculealus, CBS 101.43, recombinant vectors and cells comprising said construct and a method for producing said enzyme using said cell comprising said construct.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: March 6, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Lene Venke Kofod, MArkus Sakari Kauppinen, Stephan Christgau, Hans Peter Heldt-Hansen, Henrik Dalbøge, Lene Nonboe Andersen, Joan Qi Si, Tina Sejersgård Jacobsen, Niels Munk, Anette Müllertz
  • Patent number: 6190905
    Abstract: An isolated and purified enzyme exhibiting protease activity at a pH of 4-7 which exhibits protease in 5% hydrogen peroxide and which is encoded by a DNA sequence which hybridizes to a DNA sequence depicted in SEQ ID NO: 1 or 2. Methods are described for using the protease compositions in reducing vescosity, cleaning contact lenses, baking, and preparing animal feed.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: February 20, 2001
    Inventors: Henrik Dalbøge, Stephan Christgau, Lene Nonboe Andersen, Lene Venke Kofod, Markus Sakari Kauppinen, Jack Bech Nielsen, Claus Dambmann
  • Patent number: 6159718
    Abstract: An enzyme exhibiting polygalacturonase activity, which enzyme is immunologically reactive with an antibody raised against a purified polygalacturonase derived from Aspergillus aculeatus, CBS 101.43. The enzyme may be produced by recombinant DNA techniques and may be used for degradation of plant cell walls, for instance in the wine and juice production.
    Type: Grant
    Filed: May 29, 1998
    Date of Patent: December 12, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Dalboege, Lene Nonboe Andersen, Lene Venke Kofoed, Markus Sakari Kauppinen, Stephan Christgau, Hans Peter Heldt-Hansen, Torben Halkier
  • Patent number: 5795764
    Abstract: An enzyme exhibiting mannanase activity, which enzyme i) is immunologically reactive with an antibody raised against a purified mannanase derived from Aspergillus aculeatus, CBS 101.43; ii) is encoded by the DNA sequences shown in SEQ ID No. 1 or an analogue of said sequence, and/or; iii) comprises the amino acid sequence shown in SEQ ID No. 2 or a sequence being an least 70% homologous thereto. The enzyme may be used for various purposes for which degradation or modification of a plant or algal cell wall material is desirable.
    Type: Grant
    Filed: September 21, 1995
    Date of Patent: August 18, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Stephan Christgau, Lene Venke Kofod, Lene Nonboe Andersen, Sakari Kauppinen, Hans Peter Heldt-Hansen, Henrik Dalboege
  • Patent number: 5723328
    Abstract: An enzyme from Aspergillus aculeatus exhibiting endoglucanase activity, which enzyme is designated EG II or EG IV and is encoded by a DNA sequence comprising at least one of the partial sequences shown in SEQ ID NO: 17, 18, or 19. The enzyme may be produced by recombinant DNA techniques and may be used for degradation of plant cell wall material.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: March 3, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Dalboege, Lene Nonboe Andersen, Lene Venke Kofod, Markus Sakari Kauppinen, Stephan Christgau